Albemarle Corporation announced that Matt Juneau, executive vice president, Corporate Strategy & Investor Relations, is retiring from the company in March 2018 and that it has named Eric W. Norris as Albemarle's chief strategy officer, effective immediately. As chief strategy officer, Norris will be responsible for both Corporate Strategy and Investor Relations. Juneau will be retiring after more than 35 years with Albemarle Corporation and its predecessor, Ethyl Corporation. During his career at Albemarle, Juneau has served in positions of increasing responsibility, including senior vice president, president, Performance Chemicals, vice president, Polymer Solutions and vice president, Global Sales and Services. Norris joins Albemarle as a seasoned executive with over 20 years of diverse experience in corporate development and business leadership. Prior to joining Albemarle, he served in several roles with FMC Corporation over a 15-year period. Most recently, he served as president, FMC Health and Nutrition, where he was responsible for leading a segment with over $750 million of revenue, 13 stand-alone plants and 12 globally dispersed R&D centers, and over 1,000 employees. Prior to taking on that role, Norris served for five years in FMC's Lithium segment, first as global commercial director before moving up to vice president and global business director. Other roles at FMC included director, Corporate Development, and in its BioPolymer segment, director, Healthcare Ventures.